Turn Therapeutics TTRX
NASDAQ TTRX
$14.18 +0.77 (+5.83%)
As of: Sep 30, 2026 · 2:44 PM EDT

Turn Therapeutics (TTRX) Net Cash Flow (2024 - 2026)

Updated

Turn Therapeutics' Net Cash Flow came in at -$972,990 for Q2 2026, compared with $1.65 million a year earlier.

Analysis

Turn Therapeutics (TTRX) Net Cash Flow (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Turn Therapeutics reported Net Cash Flow of $7.02 million; for FY2025, it was $4.17 million.

  • Going back by year, Net Cash Flow was -$308,398 in FY2024.
  • Business Quant data shows TTRX's Net Cash Flow at $6.14 million (Q1 2026), $1.94 million (Q4 2025) and -$87,153 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -1.27 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -2.82 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 1.53 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 757.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 1.62 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 1.95 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -4.43 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -722.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 652.90 Mn
10 Turn Therapeutics 399.46 Mn 399.46 Mn - -972,990.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -972,990.00
Mar 31, 2026 6.14 Mn
Dec 31, 2025 1.94 Mn
Sep 30, 2025 -87,153.00
Jun 30, 2025 1.65 Mn
Mar 31, 2025 700,034.00
Dec 31, 2024 83,819.00
API Access

Turn Therapeutics Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=TTRX&period=max&api_key=YOUR_API_KEY